Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 9
2003 4
2004 6
2005 9
2006 8
2007 13
2008 15
2009 18
2010 19
2011 31
2012 26
2013 27
2014 40
2015 29
2016 28
2017 32
2018 51
2019 55
2020 62
2021 77
2022 58
2023 43
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

569 results

Results by year

Filters applied: . Clear all
Page 1
End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan hematology Study Group (W-JHS) NHL01 trial.
Kato K, Izutsu K, Nishikori M, Shibayama H, Maeda Y, Yoshimura K, Tateishi U, Miyamoto T, Matsuda Y, Ishikawa J, Rai S, Takahashi T, Yamauchi T, Matsumura I, Akashi K, Kanakura Y, Suzumiya J. Kato K, et al. Among authors: maeda y. Int J Hematol. 2024 Mar 22. doi: 10.1007/s12185-024-03738-8. Online ahead of print. Int J Hematol. 2024. PMID: 38519820
A Prompt Diagnosis and Treatment of a Case of Nuclear Protein of the Testis Carcinoma Characterized by a Bronchial Lesion and High Serum Alpha-fetoprotein Level Following Genomic Testing.
Matsuura H, Makimoto G, Oda N, Ninomiya K, Higo H, Fujii M, Rai K, Ichihara E, Ohashi K, Hotta K, Tabata M, Maeda Y. Matsuura H, et al. Among authors: maeda y. Intern Med. 2024 Feb 26. doi: 10.2169/internalmedicine.2938-23. Online ahead of print. Intern Med. 2024. PMID: 38403772 Free article.
Chimeric antigen receptor T-cell therapy after COVID-19 in refractory high-grade B-cell lymphoma.
Hayashino K, Seike K, Fujiwara K, Kondo K, Matsubara C, Terao T, Kitamura W, Kamoi C, Fujiwara H, Asada N, Nishimori H, Ennishi D, Fujii K, Fujii N, Matsuoka KI, Maeda Y. Hayashino K, et al. Among authors: maeda y. Int J Hematol. 2024 Apr;119(4):459-464. doi: 10.1007/s12185-024-03711-5. Epub 2024 Feb 13. Int J Hematol. 2024. PMID: 38349446 Free PMC article.
569 results